alexa Webster Centre for Infectious Diseases

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Webster Centre for Infectious Diseases

The Webster Centre for Infectious Diseases is a part of the University of Otago. The mission of Webster Centre for Infectious Diseases is to provide molecular solutions to problems in infectious diseases through the application of modern methods of molecular and translational research. The Webster Centre for Infectious Diseases provides undergraduate, postgraduate programs. The scope extends from molecular research to clinical, epidemiological, and pharmacological research on infectious diseases affecting animals, plants, and humans. Our Centre combines the strength of our academic research (from across four universities) with Crown Research Institutes. This provides us with a comprehensive framework for basic, clinical and epidemiological studies. Over sixty experts from four universities, and key Crown Research Institutes are working to translate discoveries into practical applications against infectious diseases. Webster Centre scientist, Dr Jo Kirman, researches applied and molecular immunology. Webster Centre researchers, including Professor Andy Mercer, are working on a programme on human pathogenic viruses, drug targets, and potential therapeutics. Webster Centre scientist, Dr James Ussher, researches immunity to bacterial infection. Dunedin researchers Professors Greg Cook, Philip Hill and Frank Griffin are key leaders in a group of Otago scientists studying tuberculosis, and other mycobacterial diseases. Webster Centre scientists Associate Professor Russell Poulter and Professor Iain Lamont have been investigating the bacterial causes of diseases in New Zealand kiwifruit. Professor Kurt Krause carries out research on structural biology of infectious diseases and antimicrobial development